- cafead Mar 15, 2024 at 11:22: AM
via
article source
- Pfizer's pipeline already includes two obesity drugs.
- However, doubts about Pfizer's lead obesity program could make buying Viking a smart move.
- The best bet is that Pfizer will wait for additional data before moving forward with any potential acquisition.
article source